Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/28/2008US20080207768 Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom
08/28/2008US20080207766 Using N,2,3,3-tetramethylbicyclo92.1.1)heptane-2-amine ; side effect reduction
08/28/2008US20080207765 Using a phenylenediamine compound
08/28/2008US20080207764 Novel Benzamidine Derivatives Having Anti-Inflammatory and Immunosuppressive Activity
08/28/2008US20080207763 Synergistic mixture of analgesics and endothelin antagonist; fever therapy
08/28/2008US20080207762 Method of treating inflammatory acne vulgaris with carbamide peroxide
08/28/2008US20080207761 Pharmaceutical formulations of modafinil
08/28/2008US20080207760 Pharmaceutical Compositions For and Methods of Inhibiting Hcv
08/28/2008US20080207759 Prevent damage in mammals by administering prostaglandins
08/28/2008US20080207758 Reaction product of rhein with bases or amino acids; antidiabetic agents; gastrointestinal disorders; antiarthritic agents
08/28/2008US20080207757 Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same
08/28/2008US20080207756 Dispensing liquid for coating interior body tissue; prevent tissue dessciation during surgery
08/28/2008US20080207755 Administering 3-aminomethyl-5-methyloctanoic acid; syndrome; analgesics; urogenital system pain
08/28/2008US20080207754 Method and apparatus for palatable prevention of acid reflux
08/28/2008US20080207753 Antiinflammatory agents; cardiovascular disorders; vision defects; skin disorders; central nervous system disorders; antiarthritic agents
08/28/2008US20080207752 Poly (epsilon-caprolactone-co-methylmethacrylate), method for preparing the same using super critical fluid, and method for preparing therapeutic agent for skin diseases such as acne, atopy and athlete's foot comprising the same
08/28/2008US20080207751 Non-steroid antiinflammatory compound derivative of sulindac
08/28/2008US20080207750 Use of N-Chlorotaurine for Treatment of Oozing Tissue Deficiencies
08/28/2008US20080207749 Gastrointestinal disorders; urogenital disorders
08/28/2008US20080207748 Vitamin c preparation
08/28/2008US20080207747 Lipase Inhibitors
08/28/2008US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound
08/28/2008US20080207745 Orally-absorbed formulation for paromomycin
08/28/2008US20080207744 Anticancer agents
08/28/2008US20080207743 Anticancer agents
08/28/2008US20080207742 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury
08/28/2008US20080207741 Chronic onstructive pulmonary disease; adult respiratory distress syndrome; antiinflammatory agents; skin disorders; autoimmune diseases; multiple sclerosis; antihistamines; inflammatory bowel disorders
08/28/2008US20080207740 Small organic molecule regulators of cell proliferation
08/28/2008US20080207739 Sphingosine phosphate receptor antagonist
08/28/2008US20080207738 In cancer; using xanthene compound; blocking multidrug resistant protein
08/28/2008US20080207737 Methods for the Treatment of Hyperhidrosis
08/28/2008US20080207736 Chronic obstructive pulmonary diseases; asthma
08/28/2008US20080207735 1-Amino Linked Compounds
08/28/2008US20080207734 Novel alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction
08/28/2008US20080207733 Composition for the Treatment of Vitiligo
08/28/2008US20080207732 Obesity; cognition activators; narcolepsy
08/28/2008US20080207731 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
08/28/2008US20080207730 Methods of using (+)-2-[1-(3-Ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione
08/28/2008US20080207729 Chemoosensitizer for dug resistance tumors
08/28/2008US20080207728 Bicyclic acyltryptophanols
08/28/2008US20080207727 Antiinflammatory agents; antitumor agents; Alzheimer's disease;atherosclerosis
08/28/2008US20080207726 Reacting carvediol with phosphoric acid; precipitating ; reducing impurities.
08/28/2008US20080207725 Skin disorders; antiinflamamtory agenst; antiallergens
08/28/2008US20080207724 Use of Inhibitors of Histone Deacteylases in Combination With Compounds Acting as Nsaid for the Therapy of Human Diseases
08/28/2008US20080207723 Diagnosing tumor disorder in humans; extraction of nucleotide ; calibration; monitoring concentration ; quantitative analysis
08/28/2008US20080207722 Glepp-1 Inhibitors in the Treatment of Autoimmune and/or Inflammatory Disorders
08/28/2008US20080207721 Chemical compounds
08/28/2008US20080207720 Novel Imidazolecarboxamide Derivatives as Fructose-1,6-Bisphosphatase Inhibitors, and Pharmaceutical Compositions Comprising Same
08/28/2008US20080207719 Treatment of Epilepsy
08/28/2008US20080207718 Antiinflammatory agents; antiallergens; chronic obstructive pulmonary disease
08/28/2008US20080207717 Composition to provide maintenance and nutritional support in glycemic control deficits
08/28/2008US20080207716 Formulations and Dosing Regiment for Ppar-Alpha Modulators
08/28/2008US20080207715 Novel Inhibitors of Glutaminyl Cyclase
08/28/2008US20080207714 Diagnosis And Treatment Of Breast Cancer
08/28/2008US20080207713 Mixture of muscle relaxant and nitrogen oxide doner; promote cell muscle proliferation repair; muscle dystrophy therapy
08/28/2008US20080207712 Thiazole-amine compounds for the treatment of neurodegenerative disorders
08/28/2008US20080207711 Polycystic kidney disease; antidiabetic agents; anticancer agents; using cyclin-dependent kinase inhibitor; prevent cell proliferation; increase cell differentiation
08/28/2008US20080207710 Side effect reduction; using activator of peroxisome proliferator activated receptors ; concurrent reduce blood sugar and cholesterol ; reduce insulin resistance
08/28/2008US20080207709 -4-[2-(aminomethyl)-1,3-thiazol-4-yl]-2,6-di(tert-butyl)phenol; : 4-[2-(aminomethyl)-1,3-thiazol-4-yl]-2,6-di(tert-butyl)phenol hydrochloride or dihydrochloride
08/28/2008US20080207708 Analgesics; antiinflammatory agents; bone disorders; neurodegenerative diseases
08/28/2008US20080207707 Aryl-substituted heterocycles, process for their preparation and their use as medicaments
08/28/2008US20080207706 Thiadiazoline derivative
08/28/2008US20080207705 Heteroaryl-Imidazole Derivatives as Cannabinoid CB1 Receptor Antagonists
08/28/2008US20080207704 Heteroaryl-imidazole derivatives as cannabinoid cb1 receptor antagonists
08/28/2008US20080207703 Antibacterial heterocyclic ureas
08/28/2008US20080207702 Use of Quaternary Pyridinium Salts as Vasoprotective Agents
08/28/2008US20080207701 Opioid receptor antagonists
08/28/2008US20080207700 Amino Acid Salts of Rosiglitazone
08/28/2008US20080207699 Pyrazole Derivatives
08/28/2008US20080207698 Novel Compounds 569
08/28/2008US20080207697 Nervous system connecting diseases such as autism
08/28/2008US20080207696 Phenacyl 2-Hydroxy-3-Diaminoalkanes
08/28/2008US20080207695 Thrombin Inhibiting 2-Oxo-1,2,5,6-Tetrahydropyridine Derivatives
08/28/2008US20080207694 Antiinflamamtory disorders; antidiabetic agents; cirrhosis; transplant rejection
08/28/2008US20080207693 Mitotic Kinesin Inhibitors
08/28/2008US20080207692 Vision defects; mixture includes source of hydrogen peroxide
08/28/2008US20080207691 Metabolic disorders; antidiabetic agents; hypoglycemic agents; obesity; hypotensive agents
08/28/2008US20080207690 Benzisoxazole Derivatives
08/28/2008US20080207689 Formamide Derivatives For The Treatment of Diseases
08/28/2008US20080207688 Novel Piperidine Derivatives
08/28/2008US20080207687 Quinoline Derivatives as Antibacterial Agents
08/28/2008US20080207686 Antibiotics
08/28/2008US20080207685 Heterocyclic Compounds As Modulators Of Peroxisome Proliferator Activated Receptors, Useful For The Treatment And/Or Prevention Of Disorders Modulated By A Ppar
08/28/2008US20080207684 Kinase inhibitors and methods for using the same
08/28/2008US20080207683 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
08/28/2008US20080207682 Phenylurea Derivatives As Inhibitors Of Tyrosine Kinases For The Treatment Of Tumour Diseases
08/28/2008US20080207681 Perfusion blood through tube coated with collagen; measure thrombosis and platelet aggregation; prevent cardiovascular disorders
08/28/2008US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
08/28/2008US20080207679 Glutathione peroxidase mimetics for the treatment of dermatoses
08/28/2008US20080207678 Viral inhibitors
08/28/2008US20080207677 Napthyridine Compounds As Rock Inhibitors
08/28/2008US20080207676 Crystalline forms of an 8-Azabicyclo(3.2.1)octane compound
08/28/2008US20080207675 Aqueous Gel Formulations Containing 1-(2-Methylpropyl)-1H-Imidazo[4,5-C][1,5]Naphthyridin-4-Amine
08/28/2008US20080207674 Immune Response Modifier Formulations And Methods
08/28/2008US20080207673 Method for Treating Cancer, Coronary, Inflammatory and Macular Disease, Combining the Modulation of Zinc-and/or Copper Dependent Proteins
08/28/2008US20080207672 Skin disorders; administering by mouth, topical, transdermal; using rapamycin compound
08/28/2008US20080207671 Using inhibitors of target of rapamycin (TOR) gene products as therapeutic agent in treatment of diabetic vision defects
08/28/2008US20080207670 Dermally Applicable Formulations For Treating Skin Diseases in Animals
08/28/2008US20080207669 (S)-N-Stereoisomers of 7,8-Saturated-4,5-Epoxy-Morphinanium Analogs
08/28/2008US20080207668 Pharmaceutical compositions of hydromorphone for prevention of overdose or abuse
1 ... 3111 3112 3113 3114 3115 3116 3117 3118 3119 3120 3121 3122 3123 3124 3125 3126 3127 3128 3129 3130 3131 ... 7860